Nonresident fellow Hagop Kantarjian, chair of the Department of Leukemia at the MD Anderson Cancer, co-authors an article on countering pharmaceutical industry efforts to delay the release of affordable generic drugs in the United States.
Read his paper in Blood, a weekly medical journal published by the American Society of Hematology.
